OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 76 filers reported holding OCULAR THERAPEUTIX INC in Q3 2019. The put-call ratio across all filers is 1.61 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,108,000 | -39.5% | 275,506 | -25.5% | 1.50% | -34.2% |
| Q1 2022 | $1,830,000 | -38.7% | 369,628 | -13.6% | 2.28% | +3.1% |
| Q4 2021 | $2,983,000 | -64.0% | 427,927 | -46.0% | 2.21% | -40.2% |
| Q3 2021 | $8,275,000 | -6.5% | 792,775 | +27.0% | 3.70% | +3.2% |
| Q2 2021 | $8,851,000 | +23.6% | 624,201 | +43.1% | 3.58% | +26.8% |
| Q1 2021 | $7,160,000 | +397.6% | 436,307 | +527.8% | 2.82% | +275.7% |
| Q4 2020 | $1,439,000 | +102.1% | 69,501 | -25.7% | 0.75% | +68.6% |
| Q3 2020 | $712,000 | +115.8% | 93,587 | +24.8% | 0.45% | +38.1% |
| Q2 2019 | $330,000 | – | 75,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |